Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | OLFML2A |
| Upstream (Parents) |
|---|
| (<<) DKK3 → OLFML2A |
| (<<) ENTPD1 → OLFML2A |
| (<<) PDGFRB → OLFML2A |
| (<<) PLAT → OLFML2A |
| (<<) LAMC1 → OLFML2A |
| Downstream (Children) |
|---|
| OLFML2A → SLIT1 (>>) |
| OLFML2A → GDNF (>>) |
| OLFML2A → GRP (>>) |
| OLFML2A → NTRK2 (>>) |
| OLFML2A → LRP2BP (>>) |
| OLFML2A → SYDE1 (>>) |
| OLFML2A → POPDC2 (>>) |
| OLFML2A → BEAN (>>) |
| OLFML2A → KRTAP5-8 (>>) |
| OLFML2A → RAB3IL1 (>>) |
| OLFML2A → MTMR8 (>>) |
| OLFML2A → RUSC2 (>>) |
| OLFML2A → DYNC2H1 (>>) |
